Literature DB >> 15761222

Initial safety experience of abciximab and heparin for acute ischemic stroke.

Pitchaiah Mandava1, Scott D Lick, M A Rahman, Hans Langsjoen, K V Reddy, Jeffrey Nelson, Thomas A Kent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15761222     DOI： 10.1159/000084371

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN： 1015-9770            Impact factor:   2.762


× No keyword cloud information.
  4 in total

Review 1.  Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions.

Authors:  Pitchaiah Mandava; Perumal Thiagarajan; Thomas A Kent
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  A Pilot Trial of Low-Dose Intravenous Abciximab and Unfractionated Heparin for Acute Ischemic Stroke: Translating GP IIb/IIIa Receptor Inhibition to Clinical Practice.

Authors:  Pitchaiah Mandava; William Dalmeida; Jane A Anderson; Perumal Thiagarajan; Roderic H Fabian; Raymond U Weir; Thomas A Kent
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

3.  Recanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations.

Authors:  Vijay K Sharma; Hock Luen Teoh; Lily Y H Wong; Jie Su; Benjamin K C Ong; Bernard P L Chan
Journal:  Stroke Res Treat       Date:  2009-12-09

4.  LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack.

Authors:  Dawn M Meyer; Karen C Albright; Teresa A Allison; James C Grotta
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Jan-Feb       Impact factor: 2.136
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.